Market Movers Today: FirstEnergy Corp (FE), Juno Therapeutics Inc (JUNO), Halliburton Company (HAL), and More

Page 2 of 2

Juno Therapeutics Inc (NASDAQ:JUNO) (The Motley Fool)
What happened: In response to accepting a buyout offer, shares of Juno Therapeutics (NASDAQ:JUNO), a clinical-stage biotech focused on immunotherapies, jumped 27% as of10:30 a.m. EST on Monday. So what: It appears that the rumor was true. Investors learned on Monday that Juno accepted an all-cash buyout offer from biotech giant Celgene (NASDAQ:CELG).

Validus Holdings, Ltd. (NYSE:VR) (Benzinga)
Validus Holdings, Ltd. shares jumped 44.4 percent to $67.48 after American International Group Inc AIG 0.9% announced plans to acquire Validus for $68 per share in cash.

Novavax, Inc. (NASDAQ:NVAX) (Madison.com)
What happened: Shares of Novavax (NASDAQ: NVAX), a clinical-stage synthetic vaccine specialist, jumped by as much as 21% on heavy volume in early morning trading today. What’s up? Novavax’s shares appear to be responding positively to the news that the ongoing flu season has turned into one of the worst, and most deadly, in more than a decade.

Array Biopharma Inc (NASDAQ:ARRY) (Benzinga)
Array Biopharma Inc shares gained 15.3 percent to $15.15. Array BioPharma disclosed that combination of encorafenib, binimetinib and cetuximab demonstrated an 8 month median progression-free survival in BRAF-mutant colorectal cancer in updated safety lead-in results from BEACON Phase 3 trial.

Bioverativ Inc (NASDAQ:BIVV) (CNBC)
Bioverativ – Bioverative is soaring in premarket trading after the U.S. hemophilia treatment specialist agreed to be bought by French drugmaker Sanofi for $11.6 billion in cash, or $105 per share.

Page 2 of 2